Unlock instant, AI-driven research and patent intelligence for your innovation.

I-type crystal of N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone and manufacturing method thereof

A technology of methylsulfonylphenyl and methylphenyl, which is applied in the field of crystallization of antibacterial drugs, can solve the problems of fine crystallization of products, difficult filtration, poor fluidity, etc., and achieve no reduction in drug content, easy production, good The effect of crystal stability

Active Publication Date: 2012-01-11
JIANGSU HENGRUI MEDICINE CO LTD +1
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Generally speaking, amorphous pharmaceutical products have no regular crystal structure and often have other defects, such as fine crystallization of the product, difficult filtration, easy agglomeration, poor fluidity, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • I-type crystal of N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone and manufacturing method thereof
  • I-type crystal of N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone and manufacturing method thereof
  • I-type crystal of N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone and manufacturing method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] N-n-propyl-3-(4-methylphenyl)-4-(4-methanesulfonylphenyl)-2,5-dihydropyrrole-2-one 10.0g (according to the patent CN1318541A ​​disclosed (Prepared by the method) was added to ethanol (150ml), heated under reflux to dissolve, slowly cooled to crystallize, continue to crystallize to room temperature, and filter the precipitated crystals. The obtained crystals were dried under reduced pressure at room temperature overnight to obtain 8.86 g of crystals with a yield of 88.6%. The ethanol solvent residue in the obtained sample is 100ppm, and the melting point is 181.0~182.0℃ by capillary method; the X-ray diffraction spectrum of the crystalline sample is shown in figure 1 , It is type I crystal. DSC spectrum see figure 2 , There is a sharp melting endothermic peak at 183.87℃. The sample was dried under reduced pressure at 80°C for 4 hours, the melting point of the dried sample was measured by capillary method at 181.5-183.0°C, and the X-ray diffraction spectrum showed type ...

Embodiment 2

[0038] Add 10.0 g of N-n-propyl-3-(4-methylphenyl)-4-(4-methanesulfonylphenyl)-2,5-dihydropyrrole-2-one to methanol (150ml), Heat to reflux to dissolve, slowly cool to 35°C to start crystallization, continue crystallization to room temperature, and filter the precipitated crystals. The obtained crystals were dried under reduced pressure at room temperature overnight to obtain 8.3 g of crystals with a yield of 83%. The methanol solvent residue of the obtained sample is 200ppm, and the melting point is 181.0~183.0℃ measured by capillary method; the characteristic peaks of the X-ray diffraction spectrum of the crystalline sample are the same figure 1 , It is type I crystal. The DSC spectrum has a sharp melting endothermic peak at 184.0°C. Then, the sample was dried under reduced pressure at 80°C for 4 hours. The capillary method of the dried sample measured the melting point of 181.5-183.0°C, and the X-ray diffraction spectrum was type I crystal. The DSC spectrum has a sharp mel...

Embodiment 3

[0040] Add 10.0g of N-n-propyl-3-(4-methylphenyl)-4-(4-methanesulfonylphenyl)-2,5-dihydropyrrole-2-one to 50% ethanol (200ml) After heating and refluxing to dissolve, slowly cooling to crystallize, crystals begin to precipitate at 65°C, a large amount of crystals are precipitated at 60°C, crystallization is continued to room temperature, and the precipitated crystals are filtered. The obtained crystals were dried overnight under reduced pressure at 60°C to obtain 9.1 g of crystals with a yield of 91%. The obtained sample has a residual ethanol solvent of 500 ppm and contains 0.45% water. The melting point of the obtained sample is 181.0-182.0 DEG C by capillary method; the X-ray diffraction spectrum of the crystalline sample is type I crystal. The DSC spectrum has a sharp melting endothermic peak at 184.42°C. Then the sample was vacuum dried at 80°C for 4 hours, the moisture content of the dried sample was 0.20%, the melting point measured by capillary method was 181.0-182.5°C...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to I-type crystallization of N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone and a manufacturing method thereof. The method comprises the step of crystallizing any crystal form of or amorphous N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone solid with a polar organic solvent or aqueous solution thereof to obtain the I-type crystallization of N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone. The obtained I-type crystallization of N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone has favorable crystal form stability and chemical stability, and the utilized crystallization solvent has low toxicity and less residue, thereby the invention can be better used for clinical treatment.

Description

Technical field [0001] The invention relates to a crystalline form of an antibacterial drug, especially N-n-propyl-3-(4-methylphenyl)-4-(4-methanesulfonylphenyl)-2,5-dihydropyrrole- 2-ketone type I crystal and its preparation method. Background technique [0002] So far known cyclooxygenase isoenzymes have two subtypes: cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2). Cyclooxygenase 1 is a structural enzyme that exists in normal tissues. Its physiological function is to catalyze the oxidation of arachidonic acid to prostaglandins, and maintain the protective function of the gastrointestinal mucosa and the normal function of the kidney; cyclooxygenase 2 is Inducible enzymes, which are produced by stimulating cells such as endotoxin, cytokines or hormones, and can catalyze the production of prostaglandins to cause inflammation. At present, most non-steroidal anti-inflammatory drugs are known for their effects on the above-mentioned two enzymes. While they inhibit cyclooxyge...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D207/38A61K31/4015A61P31/04
CPCC07D207/38A61P31/04
Inventor 孙飘扬陈永江刘全文
Owner JIANGSU HENGRUI MEDICINE CO LTD